Core Scientific, Inc. (CORZ) Financial Ratios
7 years of historical data (2019–2025) · Technology · Software - Infrastructure
EV/EBITDA
N/A
—
5yr avg: 39.22
30Y Low39.2·High39.2
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
↓
N/A
—
5yr avg: -227.1%
30Y Low-461%·High6%
Debt/EBITDA
↑
N/A
—
5yr avg: 8.06
30Y Low4.1·High13.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CORZ Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Core Scientific, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.0B | $4.6B | $3.6B | — | — | — | — | — |
| Enterprise Value | $7.7B | $5.4B | $4.0B | — | — | — | — | — |
| P/E Ratio → | -25.22 | — | — | — | — | — | — | — |
| P/S Ratio | 21.86 | 14.52 | 7.04 | — | — | — | — | — |
| P/B Ratio | — | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | 25.06 | 16.64 | 83.79 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
CORZ EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 16.86 | 7.75 | — | — | — | — | — |
| EV / EBITDA | — | — | 39.22 | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
CORZ Profitability
Margins and return-on-capital ratios measuring operating efficiency
Core Scientific, Inc. earns an operating margin of -45.4%. Operating margins have compressed from 1.8% to -45.4% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.9% | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% | 17.7% |
| Operating Margin | -45.4% | -45.4% | -3.8% | 1.8% | -329.5% | 30.6% | -10.5% | -19.6% |
| Net Profit Margin | -90.5% | -90.5% | -257.5% | -49.1% | -335.2% | 8.7% | -20.2% | -20.0% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | -460.7% | 6.4% | -9.1% | -8.8% |
| ROA | -14.6% | -14.6% | -113.8% | -32.4% | -132.2% | 3.6% | -6.3% | -7.4% |
| ROIC | — | — | — | 3.1% | -191.2% | 11.3% | -3.1% | — |
| ROCE | -9.5% | -9.5% | -2.3% | 2.1% | -154.0% | 14.7% | -4.2% | -8.2% |
CORZ Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $749M ($1.1B total debt minus $311M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.61 | 0.30 | 0.06 |
| Debt / EBITDA | — | — | 11.89 | 8.21 | — | 4.09 | 13.10 | — |
| Net Debt / Equity | — | — | — | — | — | 0.52 | 0.24 | 0.01 |
| Net Debt / EBITDA | — | — | 3.60 | 7.73 | — | 3.50 | 10.28 | — |
| Debt / FCF | — | — | — | 16.65 | — | — | — | — |
| Interest Coverage | -44.16 | -44.16 | -0.52 | 0.10 | -21.79 | 3.76 | -1.43 | -49.73 |
CORZ Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.15x means Core Scientific, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.20x to 1.15x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | 1.02 | 0.57 |
| Quick Ratio | 1.15 | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | 1.02 | 0.57 |
| Cash Ratio | 0.40 | 0.40 | 6.21 | 0.10 | 0.09 | 0.37 | 0.12 | 0.34 |
| Asset Turnover | — | 0.14 | 0.32 | 0.71 | 0.79 | 0.22 | 0.27 | 0.37 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | 0.73 | 5.20 | 2.02 | 1.13 | 6.70 | 1.76 |
CORZ Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Core Scientific, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $318M | $256M | $380M | $341M | $233M | $380M | $380M |
Peer Comparison
Compare CORZ with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CORZYou | $7B | -25.2 | — | — | 11.9% | -45.4% | — | — | — |
 RIOT | $8B | -10.4 | — | — | -15.6% | -61.8% | -22.1% | -8.7% | — |
 MARA | $5B | -3.3 | — | — | -47.7% | -90.6% | -34.5% | -9.0% | — |
 CLSK | $3B | 12.0 | 6.3 | — | 41.6% | 41.6% | 18.5% | 10.3% | 1.2 |
 CIFR | $9B | -10.3 | 384.9 | — | -60.5% | -76.7% | -108.3% | -5.9% | 95.9 |
 BTBT | $577M | 8.9 | 8.3 | — | 61.9% | 16.8% | 9.2% | 6.5% | 0.2 |
 HUT | $9B | -37.6 | — | — | 91.3% | -136.9% | -16.9% | -14.0% | — |
 IREN | $18B | 140.4 | 93.7 | — | 68.3% | 3.5% | 6.0% | 0.7% | 4.9 |
 WULF | $10B | -111.9 | — | — | 55.3% | -54.4% | -31.0% | -10.6% | — |
 BITF | $1B | -16.6 | 37.6 | — | -16.8% | -55.8% | -12.0% | -17.1% | 0.7 |
 MIGI | $4M | -0.1 | — | 2.6 | 34.2% | -52.6% | -339.9% | -62.9% | — |
| Technology Median | — | 26.7 | 17.5 | 19.5 | 48.9% | -0.6% | 2.5% | 3.0% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See CORZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CORZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CORZ vs RIOT
Side-by-side business, growth, and profitability comparison vs Riot Platforms, Inc..
Start ComparisonCORZ — Frequently Asked Questions
Quick answers to the most common questions about buying CORZ stock.
What is Core Scientific, Inc.'s P/E ratio?
Core Scientific, Inc.'s current P/E ratio is -25.2x. This places it at the 50th percentile of its historical range.
Is CORZ stock overvalued?
Based on historical data, Core Scientific, Inc. is trading at a P/E of -25.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Core Scientific, Inc.'s profit margins?
Core Scientific, Inc. has 11.9% gross margin and -45.4% operating margin.